graphic/j_jhp00096_fig_001.jpg

Von Willebrand disease (VWD) is the most common hereditary coagulation abnormality, presenting in an estimated 1% of the population [1, 2, 3, 4, 5, 6]. In those with VWD, there is a deficiency or dysfunction of von Willebrand factor (VWF), a plasma protein that controls platelet haemostatic function and stabilises blood clotting with factor VIII (FVIII). Those with VWD often experience symptoms related to mucosal bleeding, with VWF levels greatly affecting the amount of bleeding experienced. Symptoms include epistaxis, gingival bleeding, menorrhagia and easy bruising. Women tend to have more intense symptoms than men, mostly relating to their menstrual cycle [1, 2, 3, 4, 5, 6, 7].

Gingival bleeding is often reported in those with VWD, but recent efforts have been made to determine whether gingival bleeding is a true symptom and result of VWD. Studies examining the relationship between VWD and gingival bleeding have conflicting results; however, this may be due to indirect effects of VWD on confounding factors such as oral hygiene. For example, a study by Urdaneta and colleagues found that those with VWD had significantly more plaque and poorer oral hygiene than those without VWD [3].

Research has shown that many patients with bleeding disorders have a fear of performing tasks that may increase bleeding, such as removing plaque with brushing and flossing. Consequently, it has been reported that patients with bleeding disorders generally have poorer oral hygiene than those without bleeding disorders [3]. Research has also shown a relationship between the presence of plaque and a higher risk for dental caries (cavities) and periodontal (gum) disease [8, 9, 10, 11, 12]. Therefore, if those with VWD are not properly removing plaque due to fear of causing gingival bleeding, they are putting themselves at a higher risk of developing dental caries and periodontal disease.

Dental caries in permanent teeth is the most prevalent disease worldwide. The presence of dental plaque on the tooth is necessary for a cavity to form [9]. When carious lesions (cavities) are not addressed, there is potential for the lesion to extend deep into the nerve of the tooth, causing a systemic infection and/or causing the need for an extensive restoration or removal of the tooth itself.

Under the umbrella of periodontal diseases, gingivitis and periodontitis are the most prevalent diseases of the periodontium, the soft and hard tissues that surround the tooth. Alarming data from the National Health and Nutrition Examination Survey (NHANES) shows that 47.2% of American adults have periodontitis and even more American adults have gingivitis [8]. Gingivitis and periodontitis are caused primarily by the presence of bacterial plaque and bleeding is often the first sign of periodontal disease. [9, 10, 11, 12, 13]

Gingivitis is typically characterised as bleeding, redness and swelling of the gingiva. When gingivitis progresses into the other supporting structures of the periodontium, periodontitis occurs, causing destruction of the bone that surrounds the teeth and leading to mobility and eventual tooth loss. Though this process typically takes years to cause tooth loss, it is typically related to the amount of plaque present on the tooth surface [9, 10, 11, 12, 13]. Other factors, such as age, social habits, medical conditions, medications and genetic factors also play a role [8]. Scientific evidence shows a correlation between periodontal disease and systemic conditions such as heart disease, stroke and diabetes [9, 10, 11, 12, 13].

In addition, those with VWD (along with other bleeding disorders) are at higher risk for severe treatment complications, especially after dental treatments such as extractions and local anaesthesia [14, 15, 16]. Patients with VWD therefore require dental treatment accommodations. However, this bleeding disorder is unfamiliar to many oral health care providers and many do not have experience in treating patients with coagulation disorders, especially VWD [3,14,16,17].

Due to the increased risk of treatment complications in VWD patients, preventive dentistry and oral health education is of great importance in order to minimise the need for extensive dental procedures. Efforts are being made to address this issue in the US. For example, in the United States some bleeding disorder clinics have a dental hygienist available during the clinic appointment to review oral health education with those with VWD and their oral healthcare providers, enabling the safe and effective treatment of these patients [3,14,16,17]. In the state of Michigan the majority have a DH as an active member of the hematology team. One of the early signs of periodontal disease is bleeding gums; thus, monitoring for gingival bleeding can be helpful in detecting and treating oral disease in its early stages. However, patients with VWD may have excessive gingival bleeding due to the lack of VWF. In order to implement preventive oral health measures in this patient population effectively, it is therefore important to first understand the effect of VWD on gingival bleeding.

The purpose of this cross-sectional pilot study was to determine the relationship between VWF levels and gingival bleeding when controlling for possible confounding variables, including age, plaque, oral hygiene habits and dental care utilisation. By understanding the relationship between VWD and gingival bleeding, providers will be able to better address oral hygiene as a preventive agent for periodontal disease. In addition, the study sought to determine the effectiveness of having a dental hygienist at bleeding disorder clinics to provide oral health education.

Materials and methods

Women aged 18 or older with VWD were eligible to participate in the study if they had at least 12 teeth present and were capable of providing informed consent. The study focused on women because of the detrimental effects that VWD has on women related to menstrual bleeding [7]. Exclusion criteria comprised those with uncontrolled diabetes, significant psychiatric illness that would interfere with the completion of the survey, or taking medications that cause gingival enlargement (eg calcium channel blockers, anti-seizure medications and immunosuppressants).

Variables and instruments used

Informed consent was documented prior to any data collection. After reading and signing the informed consent document, a 34-question survey was given to the participant to fill out. The survey asked questions about demographics, social behaviours, how often oral hygiene is reviewed at the individual’s bleeding disorder clinic appointment, perception of oral health, oral hygiene habits, dental care utilisation, and potential issues around access to dental care.

A clinical oral examination was performed to assess the amount of plaque and gingival bleeding. Data was gathered on the six Ramfjord teeth – designated teeth that are likely to give a good representation of the entire mouth for data collection purposes (teeth numbers 3, 9, 12, 19, 25, and 28) [18]. Presence of plaque was documented as 1, and no plaque was documented as 0. The gingival bleeding index was used to detect gingival bleeding on the six Ramfjord teeth [18]. This was assessed by employing a gentle C-wrap floss technique subgingivally, then assessing the presence or absence of bleeding. Absence of gingival bleeding was recorded as 0, and the presence of gingival bleeding was recorded as 1. Data was collected on 12 surfaces, with a total of two surfaces per tooth.

Information from the patient’s medical chart recording the patient’s most recent VWF levels and date, treatment for VWD, other medical conditions and other medications was also gathered.

Sample size estimation

The study was designed to achieve at least a 45% difference in the occurrence of gingival bleeding when plaque is present in the twelve sites measured for the study. A power calculation was generated. Based on a study by Pizzo et al., it was determined that a sample size of 38 women would provide for at least 80% power that there would be a 45% or greater incidence of gingival bleeding when plaque is present [19].

Statistical Analysis

All statistical analyses were performed using the Statistical Package for Social Sciences (SPSS) program, version 19.0 for Windows. Paired samples t-tests, logistic regression and multiple linear regression models were used to analyse the data gathered. All results were considered significant for a level of α<0.05.

Results

Descriptive statistics

A total of 44 women with VWD who met all the eligibility criteria completed the study. The majority were between the ages of 18 and 30, Caucasian, unemployed and had dental insurance. The average age was 39.1 +/- 15.8. The majority were non-smokers and used alcohol. Most participants had an education level of high school and/or some college. The descriptive characteristics of the 44 women subjects in the study are shown in Table 1.

Table 1

Demographics of sample

PERCENTAGE
N (%)
18-30 18 40.9
31-50 14 31.8
51-70 12 27.3
Race
Caucasian 34 77.3
African American 4 9.1
Asian 0 -
Hispanic 2 4.5
Other 2 4.5
Refused 2 4.5
Education
Less than high school 0 -
High school and/or some 22 50.0
college
College degree 21 47.7
Refused 1 2.3
Employment
None 22 50.0
Part-Time 4 9.1
Full-Time 17 38.6
Refused 1 2.3
Dental Insurance
Yes 32 72.7
No 11 25.0
Refused 1 2.3
Alcohol Use
Yes 27 61.9
No 16 36.4
Refused 1 2.3
Tobacco Use
Yes 2 4.5
No 40 90.9
Refused 2 4.5
Bleeding Disorder Treatment Center
University of Michigan 20 45.5
Michigan State University 24 54.5

The majority of participants attend the bleeding disorder clinic at Michigan State University. 65% stated that oral hygiene is reviewed at their bleeding disorder clinic appointments frequently or at every visit. Only 15% of individuals stated that oral hygiene was never reviewed at these appointments. This was not specific to the clinic in which the individual attended. Of those surveyed, 57.5% stated that a dental hygienist at their bleeding disorder clinic is the primary provider that reviews oral hygiene education (data not shown).

Data regarding perception of oral health, self-reported gingival bleeding and oral hygiene habits is shown in Table 2. Although 73.8% of the women surveyed have dental insurance, only 56.1% had attended a dental appointment within the last six months. For 29.3% of women, it had been more than a year since their last appointment with a dentist. Open-ended questions were used to assess whether potential issues around access to dental care existed. The responses to these questions can be found in Table 3.

Table 2

Perception of oral health, importance of oral health, frequency of gingival bleeding and oral hygiene habits

PERCENTAGE
N (%)
Gingival health condition
Poor 1 2.3
Fair – good 31 70.5
Very good – excellent 11 25.0
Refused 1 2.3
Dental health condition
Poor 3 6.8
Fair – good 32 72.7
Very good – excellent 8 18.2
Refused 1 2.3
Importance of oral health
Very important 36 81.8
Somewhat important 7 15.9
Not at all important 0 0
Refused 1 2.3
Gum bleed
More than twice a month 20 45.5
1-2 times per month 10 22.7
Less than once a month 11 27.5
Refused 3 6.8
Bleeding with brushing
Never 2 4.5
Hardly ever – on occasion 25 36.4
Fairly often – very often 16 56.8
Refused 1 2.3
Bleeding with flossing
Never 4 9.1
Hardly ever – on occasion 17 38.6
Fairly often – very often 18 40.9
Refused 5 11.4
Frequency of brushing
Less than once a day 2 4.5
Once a day 7 15.9
More than once a day 31 70.5
Refused 4 9.1
Frequency of flossing
Less than once a week 12 27.3
1 – 6 times per week 14 31.8
At least once per day 14 31.8
Refused 4 9.1
Table 3

Possible complications interfering with access to dental care for women with von Willebrand disease (VWD)

QUESTION PERCENTAGES (%) RESPONSES
Have you ever avoided seeing a dentist? Yes – 38.6
Financial – 55.6
Anxiety – 44.4
No – 59.1
Refused – 2.3
“No insurance”
“Anxiety, fear, afraid, pain”
“I was told I bleed a lot”
“Dislike the dentist”
“It’s not fun finding someone you trust”
“Not feeling comfortable with their knowledge of my bleeding disorder”
Has an oral health care provider ever refused you treatment because of the possibility of bleeding disorder complications? Yes – 13.6
No – 84.1
Refused – 2.3
“Because of high danger of bleeding”
“I have been sent away many times just for a basic cleaning”
“It was tough at first to find a dentist who wasn’t nervous about liability of a BD when I was a kid”
“Refused to see [me] because I had a blood disorder”
“My bleeding time was 15 minutes”
Have you ever felt any bias from an oral healthcare provider that you thought was due to your bleeding disorder? Yes – 9.1
No – 79.5
Refused – 11.4
“High bleeding risk”
“Not willing to treat me”
“It was tough at first to find a dentist who wasn’t nervous about the liability of a BD when I was a kid”
“Complains about all the blood”

For data analysis purposes, the patients’ VWD severity was classified into three groups, according to their most recent VWF reading, as follows: 1= VWF less than or equal to 30; 2= VWF 31-60; 3= VWF higher than 60. Of the women who participated in the study, 16.3% had a VWF level of less than or equal to 30, 14% had a VWF level between 31 and 60, and 53.5% had a VWF level of more than 60. Although a VWF level of greater than 60 is considered to be at the lower end of normal, as previously stated, VWF levels can fluctuate in times of stress, exercise and hormonal changes. Data were missing on five individuals as lab values for VWF were not present in their medical charts.

Clinical measures

On average, women had 7.34 (SD=4.46) sites of plaque and 2.41 (SD=2.55) sites of bleeding out of a possible 12 sites. The clinical data is shown in Table 4. When the data was stratified by VWF levels, it was also found that those with lower levels of VWF have less plaque and less gingival bleeding than those with closer to normal VWF levels. A visual representation of this data is shown in Figures 1 and 2.

Table 4

Frequency table: number of sites with plaque and bleeding of 12 sites measured per person

NUMBER OF SITES WITH PLAQUE FREQUENCY PERCENTAGE (%)
0-4 12 27.4
5-8 7 15.9
9-12 25 56.8
NUMBER OF SITES WITH BLEEDING FREQUENCY PERCENTAGE (%)
0-4 34 77.3
5-8 9 20.5
9-12 1 2.3
Figure 1

Average number of sites (of 12 measured sites) with plaque, stratified by VWF level

graphic/j_jhp00096_fig_002.jpg
Figure 2

Average number of sites (of 12 measured sites) with plaque, stratified by VWF level

graphic/j_jhp00096_fig_003.jpg

To determine the relationship between plaque and gingival bleeding, each site in the mouth had one of four possible outcomes, as follows:

graphic/j_jhp00096_fig_004.jpg

On average, 44.33% (n=5.32) of the 12 sites had plaque, but no bleeding; 35.58% (n=4.27) of the 12 sites had no plaque and no bleeding; 16.25% (n=1.95) of the 12 sites had plaque with bleeding; and only 3.75% (n=0.45) of the 12 sites had no plaque with bleeding (see Table 5).

Table 5

Average number of sites (of 12 sites measured) and standard deviations for each possible clinical outcome (Y=Yes, N=No, P=Plaque, B=Bleeding)

MEAN SD
YPYB 1.95 2.27
YPNB 5.32 4.36
NPYB 0.45 0.76
NPNB 4.27 4.31

When examining the effects of plaque on gingival bleeding, two main questions were tested with data analysis. Firstly, the number of sites that had plaque with bleeding (YPYB) was compared to the number of sites that had bleeding but no presence of plaque (NPYB). This answered the question “When bleeding was noted, is the bleeding more related to the presence of plaque or not?” Secondly, the number of sites that had plaque with bleeding (YPYB) was compared to the number of sites that had plaque with no bleeding (YPNB). Comparing these two measures provided the answer to the question “When plaque was present, is the site likely to have gingival bleeding or not?”

Statistically significant differences were noted between the mean differences in YPYB vs. NPYB and YPYB vs. YPNB groups when assessed using paired sample t-tests (p<0.001), (see Table 6). This shows that when there is plaque present on a surface, it is more likely not to bleed when using the gentle C-wrap flossing technique. Though studies have shown the relationship between plaque and gingival bleeding, low amounts of gingival bleeding were noted when using the C-wrap technique in this group, even with the presence of plaque. The second test shows that when gingival bleeding is noted, it is more likely due to the presence of plaque. Linear regression was used to determine whether VWF level had a significant effect on the relationship noted. In both tests, VWF was not a statistically significant confounding variable (p>0.05), as shown in Table 6.

Table 6

Difference in means between possible outcome pairs, with significance for paired samples t-test and when using linear regression to control for VWF level

DIFFERENCE IN MEANS P-VALUE WHEN COMPARING MEANS P-VALUE WHEN CONTROLLING FOR VWF LEVEL
YPYB v YPNB 3.47 < 0.01 0.82
YPYB v NPYB 1.56 < 0.01 0.45
YPNB v NPYB 5.02 < 0.01 0.53
NPNB v NPYB 3.74 < 0.01 0.23
YPYB v NPNB 3.47 < 0.01 0.22
YPNB v NPNB 1.28 0.41 0.33

As an inverse relationship was noted, in that those with closer to normal VWF levels presented with more gingival bleeding, multiple linear regression was used to test for possible confounding variables. In the model shown in Table 7, age is shown to have a protective effect on the number of sites with gingival bleeding. Time since last dental visit also had a significant effect on the relationship, showing that when an individual does not visit the dentist every six months, the average number of sites with gingival bleeding increases significantly (p=0.044).

Table 7

Multiple linear regression model for bleeding in women with VWD. Dependent variable: gingival bleeding

MEAN NUMBER OF SITES WITH BLEEDING*
INDEPENDENT VARIABLES COEFFICIENT ESTIMATE STD ERROR P-VALUE 95% CI
VWF level
Less than 30 Ref Ref Ref Ref
30-60 0.367 1.145 0.750 (-1.953, 2.686)
Greater than 60 0.349 0.891 0.698 (-1.457, 2.155)
Age -0.285 0.256 0.273 (-0.804, 0.234)
Last visit to dentist
Less than 6 months ago Ref Ref Ref Ref
More than 6 months ago 1.707 0.817 0.044 (0.051, 3.363)
Data shown as mean ± SE (95% CI) *Of 12 sites measured

Since plaque had a larger effect on gingival bleeding than VWF, the effectiveness of providing oral health education was analysed. Linear regression was used to determine whether the frequency of oral health education played a role in the amount of plaque noted. For those who stated that they never received oral health education at their bleeding disorder clinic, plaque was present on 10.5 of the 12 sites measured. In those women who stated that oral hygiene education was reviewed at every visit, plaque was present on 6.8 of the 12 surfaces measured. This difference in the amount of plaque was statistically significant (p=0.03), as seen in Figure 3.

Figure 3

Percentage of sites with plaque present, according to how frequently oral health education is reviewed at the bleeding disorder treatment centre (p=0.031) (error bars represent 95% CI)

graphic/j_jhp00096_fig_005.jpg

Discussion and conclusion

To the authors’ knowledge, this was the first study to assess the relationship between VWF levels, plaque accumulation and gingival bleeding when controlling for other possible confounding variables. Previous studies have compared plaque presence and gingival bleeding in healthy individuals to those with VWD, but none have controlled for varying VWF levels or used plaque as a confounding variable for gingival bleeding [3,14,15,22]. This study sought to assess whether gingival bleeding was related to plaque even while controlling for possible confounding variables such as VWF levels, oral hygiene habits, demographics, access to dental care, and self-reported gingival bleeding.

For this particular study, severity of VWD was controlled for in the analysis to determine whether there was a trend between more bleeding sites and decreased VWF. The relationship between VWF level and gingival bleeding sites was first tested with linear regression. This relationship was not significant, prompting the need to test confounding variables. Age and last dental appointment seemed to have a greater effect on the amount of gingival bleeding noted in each patient. Though not a statistically significant relationship, the amount of gingival bleeding decreased as age increased. Having a dental visit within the past six months had a protective effect on the amount of bleeding.

Comparison and analysis of the means of these four outcomes indicated that the presence of plaque may be more significant in causing gingival bleeding than low VWF. In fact, the majority of sites in the population involved in the study had plaque presence, but no concomitant bleeding. This study shows that there is 95% confidence that among women with VWD, the average number of sites with gingival bleeding is between 1.60 and 3.19 of 12 sites measured. The fact that a greater number of sites had no bleeding, even with presence of plaque, indicates that women with VWD can perform gentle C-wrap flossing without causing gingival bleeding, suggesting that performing normal oral hygiene interventions would not adversely affect their bleeding control. Expressing this confidently to patients with VWD can assure them that it is possible to perform proper oral hygiene effectively without causing excessive, if any, gingival bleeding.

When examining the amount of gingival bleeding and determining confounding variables related to delivering oral hygiene instruction, two questions on the patient survey were examined. The first asked, “How often does someone at your bleeding disorder clinic discuss oral health with you?”; the second asked, “Who usually discusses the importance of oral health with you?” Both variables were used to analyse the effectiveness of having a dental hygienist at bleeding disorder clinics. Results showed that there is a significant difference in both presence of plaque and gingival bleeding when controlling for these two variables. This may imply that educating patients on oral health can result in improved oral hygiene, leading to a decreased risk of developing periodontal disease. As previously stated, other confounding factors influence the development of periodontal disease as well, including, but not limited to medication, genetics, and age.

There were several limitations to the study, mostly related to limited time and resources. A longitudinal study would have been beneficial to evaluate the effects of the fluctuation of VWF levels over time [16,20]. A larger sample size would have given the study more power.

One major limitation was the lack of a true control group. In the hope of addressing this, data from the study was compared with data from the National Health and Nutrition Examination Survey (NHANES) to determine whether the presence of gingivitis differed in women with and without VWD [21]. A chi-square test was used to compare the presence of gingivitis in women with VWD and the presence of gingivitis in women from the NHANES data. When cases were weighted by N, the difference in the percentages was not significant (Pearson’s Correlation: 0.169), as shown in Table 8.

Table 8

Chi-square test for gingivitis in women from NHANES and women with VWD

NUMBER (PERCENT (%)) GINGIVITIS
Study Yes No
NHANES 1996 2173
(47.9) (52.1)
VWD 20 16
(55.6) (44.6)

[i] Cases weighted by N

Pearson’s Correlation: 0.169

Another limitation was the index used to measure presence of plaque. As the results showed that plaque was present on the majority of sites with no bleeding noted, an index measuring the amount of plaque present would have been beneficial in order to give insight into how long the plaque was present, contributing to its thickness.

Conclusion

In summary, this study found that VWF levels do not have a significant effect on the amount of gingival bleeding present, but that gingival bleeding is more a result of poor oral hygiene and lack of dental care. Sharing this information with individuals that have VWD can help them understand that gingival bleeding is not due to the bleeding disorder itself, but from not properly removing plaque. It is imperative that the VWD population understand the aetiology of periodontal disease and that, rather than being the result of low VWF levels, gingival bleeding is a sign of periodontal disease.

The study also found that the inclusion of a dental hygienist in the comprehensive team at bleeding disorder clinic may lead to improved patient oral hygiene. Ultimately, as gingival bleeding in women with VWD has been shown to be minimal and related to the presence of plaque rather than being a direct result of low VWF levels, practicing routine oral hygiene is safe and recommended in this patient population. As many women with VWD have felt bias or have been refused treatment by oral healthcare providers, the dental hygienist serves as an important liaison between the patient, the dentist and the bleeding disorder clinic. In addition, the hygienist communicates with the haematologist, explaining dental procedures so that appropriate medical recommendations can be made, thereby reducing the incidence of dental treatment complications. Improving oral care and decreasing gingival inflammation can ultimately reduce the risk of oral systemic disease.

Acknowledgments

S. VanDuine, K. Ridley, and LS. Taichman designed the research. S. VanDuine and K. Ridley collected data. S. VanDuine analysed data. C. Powell provided statistical guidance for data analysis. S. VanDuine drafted the manuscript. M. Snyder provided guidance on research design and interpretation. LS. Taichman, J. Bashutski, and K. Ridley provided editorial guidance. All authors collaborated and approved the final version of this manuscript.

We thank the University of Michigan Hematology and Coagulation Disorders Clinic, Michigan State University Center for Bleeding and Clotting Disorders, and Michigan Center for Oral Health Research.

A Rackham Graduate School Research Grant supported this study. Authors declare no competing financial interests. The authors also state that they have no interests that may be perceived as posing a conflict or bias.

References

1 

Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14: 171–232.

WL NicholsMB HultinAH Jameset alvon Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)Haemophilia200814171232

2 

Mannucci PM, Federici AB, James AH, Kessler CM. von Willebrand disease in the 21st century: current approaches and new challenges. Haemophilia 2009; 15: 1154–8.

PM MannucciAB FedericiAH JamesCM Kesslervon Willebrand disease in the 21st century: current approaches and new challengesHaemophilia20091511548

3 

Urdaneta MB, Urdaneta MB, Mendez VF, Socorro CB. Evaluating periodontal conditions in patients with von Willebrand’s disease in Hospital Universitario de Maracaibo (University Hospital, Maracaibo)-Venezuela. Med Oral Patol Oral Cir Bucal 2008; 13: 303–6.

MB UrdanetaMB UrdanetaVF MendezCB SocorroEvaluating periodontal conditions in patients with von Willebrand’s disease in Hospital Universitario de Maracaibo (University Hospital, Maracaibo)-VenezuelaMed Oral Patol Oral Cir Bucal2008133036

4 

Hassan S, Qureshi W, Donthireddy V, Kuriakose P. Congenital von Willebrand’s disease and clinical hypothyroidism. Haemophilia 2013; 19: 242–5.

S HassanW QureshiV DonthireddyP KuriakoseCongenital von Willebrand’s disease and clinical hypothyroidismHaemophilia2013192425

5 

Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101(6):2089-93. Available from: http://www.bloodjournal.org/content/bloodjournal/101/6/2089.full.pdf?sso-checked=true (accessed 9 January 2017).

JE SadlerVon Willebrand disease type 1: a diagnosis in search of a diseaseBlood20031016208993Available fromhttp://www.bloodjournal.org/content/bloodjournal/101/6/2089.full.pdf?sso-checked=trueaccessed 9 January 2017

6 

Laffan M, Lester W, O'Donnell JS, et al The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haemotology. Br J Haematol 2014; 167: 453-65.

M LaffanW LesterJS O'Donnellet alThe diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in HaemotologyBr J Haematol201416745365

7 

World Federation of Hemophilia. About bleeding disorder: von Willebrand disease, symptoms and diagnosis. May 2012. Available from: http://www.wfh.org/en/page.aspx?pid=676 (accessed 9 January 2017).

World Federation of Hemophilia. About bleeding disorder: von Willebrand disease, symptoms and diagnosisMay2012Available fromhttp://www.wfh.org/en/page.aspx?pid=676accessed 9 January 2017

8 

Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012; 91(10): 914-20.

PI EkeBA DyeL WeiGO Thornton-EvansRJ GencoPrevalence of periodontitis in adults in the United States: 2009 and 2010J Dent Res2012911091420

9 

Löe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965 Feb;36(3):177–87. Available from http://www.joponline.org/doi/10.1902/jop.1965.36.3.177 (accessed 9 January 2017).

H LöeE TheiladeSB JensenExperimental gingivitis in manJ Periodontol1965Feb36317787Available fromhttp://www.joponline.org/doi/10.1902/jop.1965.36.3.177accessed 9 January 2017

10 

Yaacob M, Worthington HV, Deacon SA, et al. Powered versus manual toothbrushing for oral health. Cochrane Database Syst Rev 2014; (6): CD002281. 10.1002/14651858.CD002281.pub3. Available from http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002281.pub3/full (accessed 9 January 2017).

M YaacobHV WorthingtonSA Deaconet alPowered versus manual toothbrushing for oral healthCochrane Database Syst Rev20146CD00228110.1002/14651858.CD002281.pub3Available fromhttp://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002281.pub3/fullaccessed 9 January 2017

11 

Farina R, Tomasi C, Trombelli L. The bleeding site: a multi-level analysis of associated factors. J Clin Periodontol 2013;40(8): 735–42. 10.1111/jcpe.12118.

R FarinaC TomasiL TrombelliThe bleeding site: a multi-level analysis of associated factorsJ Clin Periodontol20134087354210.1111/jcpe.12118

12 

Trombelli L, Takatis DN, Scapoli C, et al. Modulation of clinical expression of plaque-induced gingivitis. J Clin Periodontol 2004; 31: 239–52.

L TrombelliDN TakatisC Scapoliet alModulation of clinical expression of plaque-induced gingivitisJ Clin Periodontol20043123952

13 

Lang NP, Cumming BR, Löe H. Toothbrushing frequency as it relates to plaque development and gingival health. J Periodontol 1973; 44: 396-405.

NP LangBR CummingH LöeToothbrushing frequency as it relates to plaque development and gingival healthJ Periodontol197344396405

14 

Ziebolz D, Stühmer C, Hornecker E, et al Oral health in adult patients with congenital coagulation disorders--a case control study. Haemophilia 2011; 17: 527–31.

D ZiebolzC StühmerE Horneckeret alOral health in adult patients with congenital coagulation disorders--a case control studyHaemophilia20111752731

15 

Archer WH, Subrow HJ. Fatal hemorrhage following regional anesthesia for operative dentistry in a hemophilic. Oral Surg Oral Med Oral Pathol 1954; 7: 464–70.

WH ArcherHJ SubrowFatal hemorrhage following regional anesthesia for operative dentistry in a hemophilicOral Surg Oral Med Oral Pathol1954746470

16 

Gupta A. Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc 2007; 73: 77-83.

A GuptaBleeding disorders of importance in dental care and related patient managementJ Can Dent Assoc2007737783

17 

Wallak MB. Periodontal therapy for a patient with von Willebrand’s disease a case report. J Periodontol 1972; 43: 495–501.

MB WallakPeriodontal therapy for a patient with von Willebrand’s disease a case reportJ Periodontol197243495501

18 

Eberhard J, Grote K, Luchtefeld M, et al Experimental gingivitis induces systemic inflammatory markers in young healthy individuals: a single-subject interventional study. PLoS One. 2013;8:e55265. 10.1371/journal/pone.0055265. Available from http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0055265 (accessed 9 January 2017).

J EberhardK GroteM Luchtefeldet alExperimental gingivitis induces systemic inflammatory markers in young healthy individuals: a single-subject interventional studyPLoS One20138e5526510.1371/journal/pone.0055265Available fromhttp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0055265accessed 9 January 2017

19 

Pizzo G, Guiglia R, Licata ME, et al. Effect of hormone replacement therapy (HRT) on periodontal status of postmenopausal women. Med Sci Monit 2011; 17: PH23–7.

G PizzoR GuigliaME Licataet alEffect of hormone replacement therapy (HRT) on periodontal status of postmenopausal womenMed Sci Monit201117PH237

20 

Chen YC, Yang L, Cheng SN, et al. von Willebrand disease: a clinical and laboratory study of sixty-five patients. Ann Hematol 2011; 90: 1183–90.

YC ChenL YangSN Chenget alvon Willebrand disease: a clinical and laboratory study of sixty-five patientsAnn Hematol201190118390

21 

Taichman LS, Eklund SA. Oral contraceptives and periodontal diseases: rethinking the association based upon analysis of National Health and Nutrition Examination Survey data. J Periodontol 2005; 76: 1374–85.

LS TaichmanSA EklundOral contraceptives and periodontal diseases: rethinking the association based upon analysis of National Health and Nutrition Examination Survey dataJ Periodontol200576137485

22 

Weickert L, Miesbach W, Alesci SR, Eickholz P, Nickles K. Is gingival bleeding a symptom of patients with type 1 von Willebrand disease? A case-control study. J Clin Periodontol 2014; 41(8): 766-71. 10.1111/jcpe.12274.

L WeickertW MiesbachSR AlesciP EickholzK NicklesIs gingival bleeding a symptom of patients with type 1 von Willebrand disease? A case-control studyJ Clin Periodontol20144187667110.1111/jcpe.12274